How to Evaluate Long-Term Shareholder Value Creation in IPOs vs SPACs

The first-quarter 2025 data from the NYSE and Nasdaq reveals a stark divergence in post-listing performance: companies that completed traditional IPOs in 2024 have generated a median total shareholder return (TSR) of +8.3% from their first-day close through 31 March 2025, while de-SPAC entities over the same cohort have posted a median TSR of -14.7%. This 23-percentage-point gap is not a temporary anomaly but rather the culmination of structural differences in incentive alignment, lock-up mechanics, and information asymmetry that have been documented in academic literature and regulatory filings for over a decade. The 2024 SEC amendments to the business combination disclosure rules (SEC Release No. 33-11310, effective 1 July 2024) have further tightened the requirements for SPAC projections and target-company financial statements, narrowing the information gap but not eliminating the fundamental principal-agent conflict embedded in the SPAC structure. For CFOs and IBD analysts evaluating which listing path maximises long-term equity value, the answer depends on a granular analysis of dilution mechanics, sponsor economics, and the quality of the pre-listing price-discovery process — factors that are often obscured by headline underwriting fees or merger consideration multiples.

The most significant structural difference between a traditional IPO and a SPAC merger lies in the cost of capital at the point of listing, measured not by headline fees but by the total shareholder dilution incurred before the first public trade.

In a SPAC transaction, the sponsor typically receives a promote of 20% of the post-IPO equity as consideration for originating the vehicle and underwriting the de-SPAC process. For a USD 300 million SPAC trust, this translate to approximately 7.5 million founder shares at USD 10.00 each, representing USD 75 million in value at trust. This promote is not expensed through the income statement but is instead a direct dilution of public-shareholder equity. The SEC’s 2024 rule amendments (SEC Release No. 33-11310) now require SPACs to present this promote as a separate line item in pro forma financial statements, but the economic effect remains identical: for every USD 1.00 of trust value, approximately USD 0.20 is transferred to the sponsor before the target company receives any capital. By contrast, a traditional IPO underwriting spread for a USD 300 million offering on the Nasdaq typically ranges between 5.0% and 6.5% of gross proceeds (Nasdaq Listing Rule 5635 pricing guidance, 2024). On a USD 300 million IPO, the underwriting fee is USD 15-19.5 million — a fraction of the USD 75 million sponsor promote.

Warrant Dilution and the Overhang Problem

Beyond the promote, SPACs typically issue warrants to public investors as a sweetener — commonly one-half to one-third of a warrant per unit, each exercisable at USD 11.50. Data from the SPAC Research database (Q4 2024) shows that the median post-merger company has 12.8% of its fully diluted shares outstanding in the form of public and private placement warrants. When these warrants are exercised, they inject additional cash into the company but dilute existing shareholders. In a traditional IPO, warrant overhang is essentially non-existent — underwriters receive a customary overallotment option (typically 15% of the offering) that expires within 30 days of listing (SEC Rule 415 under the Securities Act). The permanent warrant overhang in a SPAC creates a structural overhang that depresses share price by an estimated 5-8% relative to a comparable IPO firm, according to a 2023 study by the University of Florida’s Warrington College of Business (Broughman & Fried, “SPACs and the Cost of Going Public”).

Price Discovery and Information Asymmetry

The quality of the price at which a company lists determines the baseline for all future shareholder returns. Traditional IPOs and SPACs employ fundamentally different mechanisms for establishing that price.

The Bookbuilding Process vs the Merger Negotiation

A traditional IPO uses SEC Rule 415 bookbuilding, where the lead underwriter collects non-binding indications of interest from institutional investors over a 10-14 day roadshow period. The final offer price is set based on a visible order book, with the issuer and underwriter adjusting the range in real time. Nasdaq Listing Rule 5310 requires that the IPO price be set at or above the net tangible book value per share, providing a floor. The result is a price that reflects the marginal demand from the most informed institutional buyers — hedge funds, long-only asset managers, and sector specialists who conduct independent due diligence. In a SPAC merger, the price is negotiated between the SPAC sponsor and the target company’s board of directors, often months before the shareholder vote. The implied equity value is a function of the trust value (USD 10.00 per share) minus redemptions, with no real-time market feedback. Data from the SEC’s 2024 SPAC study shows that the median de-SPAC company listed at an implied enterprise value that was 22% above the median pre-money valuation of comparable IPO companies in the same sector, suggesting systematic overpayment by SPAC acquirers.

Redemption Risk and the Cash Floor Illusion

The SPAC structure includes a mandatory redemption right: any public shareholder can redeem their shares at the trust value (USD 10.00 plus accrued interest) regardless of whether they vote in favour of the merger. This mechanism creates a cash floor that is often cited as a protective feature for public investors. In practice, the redemption right introduces a destabilising dynamic. When a target company is announced, the share price typically trades at a discount to trust value until the merger vote, reflecting the uncertainty of whether the deal will close. Data from SPAC Analytics (Q1 2025) shows that the median redemption rate for SPACs that completed mergers in 2024 was 47.3% — meaning nearly half of the trust capital was withdrawn before the merger closed. This leaves the target company with significantly less cash than the headline trust amount, often forcing the sponsor to inject additional private investment in public equity (PIPE) financing at dilutive terms. By contrast, a traditional IPO has no redemption mechanism; the issuer receives the full gross proceeds, minus underwriting fees, at listing. The cash certainty of an IPO provides a more reliable capital base for executing the business plan.

Lock-Up Structures and Post-Listing Selling Pressure

The timing and magnitude of insider selling after listing directly impacts share price stability and long-term shareholder value creation.

Traditional IPO Lock-Ups: Contractual but Flexible

Standard IPO lock-up agreements under SEC Rule 144 impose a 180-day restriction on insider sales, with the lead underwriter holding the discretion to release shares earlier. Nasdaq Listing Rule 5635 requires that at least 30% of the offering be held by non-affiliates for the first 90 days, but this is a listing requirement, not a lock-up. In practice, the 180-day lock-up is enforced by the underwriter through a contractual agreement with the issuer and selling shareholders. Data from the IPO Lock-Up Research database (2024) shows that 89% of Nasdaq-listed IPOs in 2023-2024 included a 180-day lock-up, with an average early-release rate of 12.3% — typically for strategic investors or employees with specific liquidity needs. The lock-up expiry is a known event that the market prices in advance; the average price decline on lock-up expiry day for IPOs is -1.7% (Ritter, University of Florida, 2024).

SPAC Lock-Ups: Shorter and More Porous

SPAC lock-ups are typically shorter and more negotiable. The sponsor’s founder shares are subject to a lock-up that expires 150 days after the merger close (NYSE Listing Standard 303A.00, which applies to SPAC sponsors). However, public shareholders face no lock-up — they can sell immediately after the merger closes, which explains the significant price drops in the first 30 days post-merger. Data from the SEC’s 2024 SPAC study shows that the median de-SPAC company experienced a -18.4% price decline in the first 30 trading days after the merger, compared to a -2.1% decline for IPOs over the same period. The absence of a lock-up for public shareholders in SPACs creates a structural selling pressure that traditional IPOs avoid.

Regulatory and Litigation Risk

The legal environment for SPACs has shifted materially since 2022, with implications for long-term shareholder value.

The SEC’s 2024 SPAC Rule Package

The SEC’s final rules on SPACs, effective 1 July 2024, reclassified de-SPAC transactions as effectively equivalent to traditional IPOs for liability purposes under Section 11 of the Securities Act. This means that SPAC sponsors and target companies now face the same strict liability standard for material misstatements in the business combination proxy statement/prospectus as issuers in a traditional IPO. The practical consequence is a significant increase in legal and accounting costs: the median legal fee for a de-SPAC transaction in Q4 2024 was USD 8.2 million, compared to USD 4.5 million for a comparable IPO (data from the SEC’s 2024 SPAC study). This cost is borne by the target company and its shareholders, further eroding post-merger returns.

Shareholder Litigation Patterns

Shareholder class actions against de-SPAC companies have been filed at a rate 3.4 times higher than against traditional IPO companies over the same period (Stanford Securities Class Action Clearinghouse, 2024 data). The most common allegations involve material omissions regarding the target company’s revenue projections and the sponsor’s conflicts of interest. The litigation risk is not merely a cost — it creates an overhang that depresses the share price and distracts management from operating the business. For CFOs evaluating listing paths, the expected litigation cost should be factored into the total cost of capital calculation.

Actionable Takeaways

Quantify total dilution, not just fees: Calculate the sponsor promote and warrant overhang as a percentage of post-merger equity; if the combined dilution exceeds 25%, the SPAC path is structurally inferior to an IPO for most operating companies.
Demand a 180-day lock-up from all material shareholders: If a SPAC sponsor cannot commit to a lock-up of at least 180 days for its promote shares, the alignment of interests is insufficient to protect minority shareholders.
Insist on a full IPO-style bookbuilding process: Use a pre-merger PIPE or a marketed offering to establish a price that reflects institutional demand, rather than accepting the sponsor’s negotiated valuation as final.
Factor in redemption risk when sizing the trust: Model the pro forma balance sheet assuming a 50% redemption rate; if the resulting cash balance is insufficient for the business plan, the SPAC structure is not viable.
Monitor the SEC’s 2024 rule implementation: The new liability standards under SEC Release No. 33-11310 mean that SPAC sponsors and targets face the same Section 11 exposure as IPO issuers; ensure the due diligence process meets traditional IPO standards.

The Dilution Calculus: Sponsor Promote vs Underwriting Spread

Sponsor Promote as Non-Transparent Equity Transfer